The DSB is composed of representatives from two FDA Centers and eight other federal government agencies, the Agency for Healthcare Research and Quality, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, Department of Defense.
Similar Posts
PAIN FLEX may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use PAIN FLEX, a product promoted and sold for joint pain on various websites, including Amazon.com and possibly in some retail stores.Lupin Limited – 11/21/2025
Lupin Limited – 11/21/2025. Country: India. Record Type: 483Notable Approvals | Drugs
News about human drug-related approvalsRecall Alert: Glycar SA Removes Pericardial Patch
Certain SJM Pericardial Patches from Glycar SA may not meet the required tensile strength specificationFDA Responses to Action Items Identified in 2023 Intergovernmental Working Meeting on Drug Compounding
In the most recent Intergovernmental Working Meeting on Drug Compounding, Nov. 7-8, 2023, FDA and state regulators identified three actions items. This page contains a summary of those action items and how FDA has responded.Follow Instructions for Safe Use of Hyperbaric Oxygen Therapy Devices – Letter to Health Care Providers
The FDA is reminding the public about the safe use of hyperbaric oxygen therapy devices and is providing recommendations to help reduce potential risks.